Third Harmonic Bio Inc. has announced its decision to voluntarily delist its common stock from the Nasdaq Stock Market, effective July 31, 2025. The company plans to file a Form 25 with the Securities and Exchange Commission to facilitate this delisting under Section 12(b) of the Securities Exchange Act of 1934. Following this, the company will also file a Form 15 to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act, as part of its Plan of Dissolution. The board of directors has approved a Common Stock Liquidation Distribution of $5.35 per share, with the first distribution expected in August 2025. This decision is part of the company's broader plan to wind down operations, which includes the departure of several key officers.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.